Ceftaroline Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 600 mg
Reference Brands: Teflaro (USA), Zinforo (EU)
Category:
Antibiotics
Ceftaroline is available in Injection
and strengths such as 600 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ceftaroline is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ceftaroline can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ceftaroline fosamil is a broad-spectrum cephalosporin antibiotic and a prodrug that is converted in the body to its active form, ceftaroline. It is marketed under the brand names Teflaro in the United States and Zinforo in Europe. It belongs to the newer generation of cephalosporins and is notable for its activity against methicillin-resistant Staphylococcus aureus (MRSA) and other important Gram-positive bacteria, while also retaining moderate activity against certain Gram-negative organisms.
After administration, ceftaroline fosamil is rapidly hydrolyzed to active ceftaroline, which works by binding to and inactivating penicillin-binding proteins (PBPs) located in the bacterial cell wall. These proteins are essential for the final stages of bacterial cell wall synthesis and structural maintenance. By inhibiting PBPs, the drug disrupts peptidoglycan cross-linking, weakens the bacterial cell wall, and leads to bacterial cell lysis and death.
Ceftaroline is used in the treatment of serious bacterial infections, including community-acquired pneumonia and complicated skin and skin structure infections, particularly where resistant Gram-positive pathogens are suspected or confirmed.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing